FDA Device Intelligence
Home › RANDOX LABORATORIES LIMITED › ConcizuTrace™ ELISA

ConcizuTrace™ ELISA

RANDOX LABORATORIES LIMITED · Model CZM10591 · UDI-DI 05055273218985

SES Prescription
1
510(k) clearances
0
Adverse events
0
Recalls
2
Facilities

Description

The ConcizuTrace™ ELISA device is for use in determining the concentration of the drug, concizumab, in 3.2% citrated plasma from patients with Haemophilia A & B, with and without inhibitors, who are undergoing treatment with concizumab for routine prophylaxis of bleeding episodes. The device is a sandwich ELISA. The intended users are trained laboratory professionals.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.